EC Neurology

Editorial Volume 16 Issue 12 - 2024

KV7 Potassium Channel Modulator BHV-7000: A Novel Therapy in the Treatment of Epilepsy and Other Neurological Disorders

Dr. Kaandeeban Mohanraj1, Shraddha Dwivedi2, Dr. Srijamya3* and Dr. Munawar Izhar4

1Department of Medicine, Indira Gandhi Medical College and Research Institute, Puducherry, India 2Department of Medicine, Gandhi Medical College, Bhopal, India 3Department of Neurology, Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia 4Graduate Medical Education, ABIM Board Review & Medical Education Specialist, Chicago, Illinois, USA

*Corresponding Author: Srijamya, Department of Neurology, Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia.
Received: October 24, 2024; Published: November 06, 2024



Epilepsy is a neurological disorder that arises due to abnormal electrical activity in the brain leading to unprovoked seizures. The cause for this abnormal electrical activity includes trauma, malformations, infection, drug toxicity etc. There are two major forms of epilepsy - generalised and focal epilepsy. Focal seizures constitute 60% of prevalence worldwide, making it the most common type of epilepsy.

Dr. Srijamya., et al. “KV7 Potassium Channel Modulator BHV-7000: A Novel Therapy in the Treatment of Epilepsy and Other Neurological Disorders”. EC Neurology  16.12 (2024): 01-02.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net